Posted by godhand > 2024-06-22 08:47 | Report Abuse

notice how harta is consistently there

Posted by Sslee > 2024-06-22 10:16 | Report Abuse

Anyone can explain why Harta with PE of 970.27 make it into top 4?

If harta next two quarter earning is a disappointment then what will be the price?
Will it still command a PE of 970.27?

Posted by Sslee > 2024-06-22 10:21 | Report Abuse

Tariffs on rubber medical and surgical gloves will jump to 25% from 7.5% in 2026.

Market over react to US tariff increase for glove from 7.5% to 25 % starting 2026.

So what will be the profit look like for Harta?
Is the price surge sustainable with the profit growth?

Posted by Sslee > 2024-06-22 10:27 | Report Abuse

Cost:
Raw material cost
Utility cost
Manpower cost
Logistics, shipment and marketing cost
Depreciation cost
Tax/duty cost

So compare the above cost what Malaysia glove manufacturers have advantage over China?

By the way US market is how many % of world market?
Even if China lost the US market, will China dominant market outside US?

Posted by godhand > 2024-06-22 11:06 | Report Abuse

ss lee the fact that malaysian glove can sell higher asp compared to intco already tell u a lot of stories. china is not the asp setter. look pass all the things now and look 10 years ahead. whatever u are looking at now wont make sense one.

Posted by Sslee > 2024-06-22 12:03 | Report Abuse

If China can sell at lower ASP to capture market share from emerging market then who is paying more to buy at higher ASP from Malaysia?

Is Malaysia gain or lose market share to China?

And why Harta deserved a TP of RM 4.10 28x FY27F P/E, slightly above its pre-COVID-19 5-year historical mean of 26x if it cannot grow its market share?

Still BUY. Post-earnings adjustment, we raise our TP to MYR4.10. Our DCF- derived TP implies 28x FY27F P/E, slightly above its pre-COVID-19 5-year historical mean of 26x. We like Hartalega due to its robust balance sheet, efficient operating model, and a key beneficiary of the recovery in medical glove sector. Key risks: Lower-than-expected sales volume, weaker-than- expected USD/MYR rate, and higher-than-expected raw material price.
Source: RHB Research - 23 May 2024

Posted by Sslee > 2024-06-22 12:10 | Report Abuse

Why give 28x FY27F P/E when Harta cannot grow its market share and hence the earning?

Know what is the PE for Public Bank now?

Posted by Mikecyc > 2024-06-22 14:08 |

Post removed.Why?